GPX4 and gastric cancer: Interestingly, HDAC inhibitor treatment alone has been shown to increase lipid peroxidation and modulate ferroptosis-related genes in gastric cancer cell lines (52) and studies in acute myeloid leukemia and colorectal cancer models found a synergistic effect combining HDAC inhibitors with GPX4 inhibitors (37, 38).